ReviewFrontiers in oncology2026
Visualization-driven digital technologies in oncology: current applications, technological advances, and future directions.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Precise anatomical understanding and spatial cognition are fundamental to effective oncologic management. While traditional two-dimensional imaging serves as the diagnostic standard, it often lacks the intuitive depth required for complex decision-making. This review synthesizes the role of visualization-driven digital technologies in oncology-including AI-driven 3D reconstruction, augmented reality (AR), multimodal fusion, radiomics, and digital twins-as cognitive interfaces across the entire continuum of cancer care. We comprehensively review current applications, ranging from deep learning-enhanced early screening and segmentation in pre-treatment planning to AR-guided surgical navigation and adaptive radiotherapy during treatment. Furthermore, we highlight the emerging utility of radiomics in post-treatment surveillance and the humanistic value of immersive visualization in patient education for anxiety reduction. Despite these advancements, clinical integration remains impeded by challenges related to intraoperative precision stability, economic feasibility in resource-limited settings, and data privacy risks associated with biometric re-identification. Looking ahead, we propose that the future of oncologic visualization lies in the convergence of physics-informed deep learning for dynamic motion correction, cloud-based edge computing for cost democratization, and privacy-preserving collaborative learning strategies. Current advances in visualization technologies support the transition from passive anatomical viewing toward more interactive, data-driven clinical decision support, though the integration of these approaches into comprehensive predictive models requires further prospective validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.